Xin Y L
China-Japan Friendship Hospital, Beijing.
Zhonghua Zhong Liu Za Zhi. 1992 Nov;13(6):467-9.
The results of 216 malignant tumor patients treated by DCT are presented. Cancer patients unsuitable for surgery, radiotherapy or chemotherapy are indicated for DCT, especially those with superficially located tumors, eg. melanoma, cancer of the skin, thyroid, breast and mouth. The deep seated cancers, eg. cancer of the liver, adrenal gland, lung and uterine cervix can also be treated by DCT. However, very advanced lesions and patients with generalized metastases respond poorly to DCT. The over-all response rate of DCT was 77.7%.
本文展示了216例接受双能CT(DCT)治疗的恶性肿瘤患者的结果。不适用于手术、放疗或化疗的癌症患者适合接受DCT治疗,尤其是那些肿瘤位于浅表的患者,例如黑色素瘤、皮肤癌、甲状腺癌、乳腺癌和口腔癌。深部癌症,例如肝癌、肾上腺癌、肺癌和宫颈癌也可以通过DCT治疗。然而,非常晚期的病变和有全身转移的患者对DCT反应较差。DCT的总体缓解率为77.7%。